Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Soraya, Azmi"'
Autor:
Anthony Mato, Boxiong Tang, Soraya Azmi, Keri Yang, Yi Han, Xiaowei Zhang, Lindsey Roeker, Nicola Wallis, Jennifer C. Stern, Eric Hedrick, Jane Huang, Jeff P. Sharman
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 135-144 (2023)
Abstract Ibrutinib, a Bruton's tyrosine kinase inhibitor, is often used as first‐line (1L) treatment of chronic lymphocytic leukaemia (CLL); however, it is associated with an increased risk for cardiovascular adverse events (CVAEs). This real‐wor
Externí odkaz:
https://doaj.org/article/6e2bc983c365456688227cc361fb4cc9
Autor:
Anthony R. Mato, Boxiong Tang, Soraya Azmi, Keri Yang, Xiaojuan Zhang, Jennifer C. Stern, Eric Hedrick, Jane Huang, Jeff P. Sharman
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Among patients with chronic lymphocytic leukemia (CLL) with deletion 17p (del[17p]), evidence from clinical trials for the effectiveness of single-agent ibrutinib as first-line therapy is limited. This retrospective analysis compared real-world clini
Externí odkaz:
https://doaj.org/article/eaa4a98279524f35a4baac869f3a349a
Autor:
Soraya Azmi, Syed Mohamed Aljunid, Namaitijiang Maimaiti, Al-Abed Ali, Amrizal Muhammad Nur, Madeleine De Rosas-Valera, Joyce Encluna, Rosminah Mohamed, Bambang Wibowo, Kalsum Komaryani, Craig Roberts
Publikováno v:
International Journal of Infectious Diseases, Vol 49, Iss C, Pp 87-93 (2016)
Objectives: To describe the incidence, mortality, cost, and length of stay (LOS) of hospitalized community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) in three Southeast Asian countries: Malaysia, Indonesia, and the Philippines. Me
Externí odkaz:
https://doaj.org/article/dd586541edc14b94bdf5cd448e45af03
Publikováno v:
Blood. 140:12377-12378
Autor:
Anthony R. Mato, Jane Huang, Boxiong Tang, Keri Yang, Jennifer C Stern, Jeff P. Sharman, Eric Hedrick, Soraya Azmi
Publikováno v:
Blood. 136:1-3
Introduction: Genetic risk factors play an important role in the prognosis of a patient with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). One of the strongest negative prognostic factors is the presence of a 17p deletion (d
Esophageal cancer (EC) makes up 3.2% of all cancers but ranks sixth among cancer-related deaths worldwide. This real-world analysis determined the use of PD-1/PD-L1 (PD[L]1) inhibitors in EC patients after receiving first-line therapy.Newly diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4312f6de0e6779bc5f98e341d6f856e
Publikováno v:
Journal of Clinical Oncology. 40:e19518-e19518
e19518 Background: The treatment landscape in patients with chronic lymphocytic leukemia (CLL) is changing with the approvals of Bruton’s tyrosine kinase inhibitors (BTKis) in Australia. We sought to understand the practice impact of the introducti
Autor:
Nicola Wallis, Jeff Porter Sharman, Eric Hedrick, Anthony R. Mato, Jane Huang, Jennifer C Stern, Boxiong Tang, Soraya Azmi, Keri Yang
Publikováno v:
Journal of Clinical Oncology. 39:e24044-e24044
e24044 Background: First-line (1L) ibrutinib monotherapy (IM) is commonly prescribed for CLL but is associated with cardiovascular adverse events (CVAEs) that may lead to discontinuation. Existing data are largely from clinical trials (both 1L and re
Autor:
Mark B Y, Tang, Kin Fon, Leong, Liang-Shiou, Ou, Zakiudin, Munasir, Pankaj R, Parekh, Soraya, Azmi, Wilson H H, Low, Adrian, Goh
Publikováno v:
Journal of drugs in dermatology : JDD. 14(2)
Atopic dermatitis (AD) is a highly prevalent, chronic relapsing condition in childhood with significant financial burden and impact on the quality of life of patients and caregivers. Proactive maintenance treatment with moisturizing agents is the mai
Publikováno v:
Journal of Gastroenterology, Pancreatology & Liver Disorders. 2
Objective: Similar to other parts of the world, gastroenteritis is an important cause of morbidity among children in South East Asia. We conducted a study to better understand the experience of pediatric gastroenteritis families from a parental persp